Chapter/Section Purchase

1 Study Coverage
1.1 Tourette Syndrome Drug Product Introduction
1.2 Market by Type
1.2.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tourette Syndrome Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Tourette Syndrome Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Tourette Syndrome Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tourette Syndrome Drug Sales by Region
2.4.1 Global Tourette Syndrome Drug Sales by Region (2017-2022)
2.4.2 Global Sales Tourette Syndrome Drug by Region (2023-2028)
2.5 Global Tourette Syndrome Drug Revenue by Region
2.5.1 Global Tourette Syndrome Drug Revenue by Region (2017-2022)
2.5.2 Global Tourette Syndrome Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tourette Syndrome Drug Sales by Manufacturers
3.1.1 Global Top Tourette Syndrome Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tourette Syndrome Drug in 2021
3.2 Global Tourette Syndrome Drug Revenue by Manufacturers
3.2.1 Global Tourette Syndrome Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2021
3.3 Global Tourette Syndrome Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tourette Syndrome Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tourette Syndrome Drug Sales by Type
4.1.1 Global Tourette Syndrome Drug Historical Sales by Type (2017-2022)
4.1.2 Global Tourette Syndrome Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Tourette Syndrome Drug Sales Market Share by Type (2017-2028)
4.2 Global Tourette Syndrome Drug Revenue by Type
4.2.1 Global Tourette Syndrome Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Tourette Syndrome Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2028)
4.3 Global Tourette Syndrome Drug Price by Type
4.3.1 Global Tourette Syndrome Drug Price by Type (2017-2022)
4.3.2 Global Tourette Syndrome Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tourette Syndrome Drug Sales by Application
5.1.1 Global Tourette Syndrome Drug Historical Sales by Application (2017-2022)
5.1.2 Global Tourette Syndrome Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Tourette Syndrome Drug Sales Market Share by Application (2017-2028)
5.2 Global Tourette Syndrome Drug Revenue by Application
5.2.1 Global Tourette Syndrome Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Tourette Syndrome Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tourette Syndrome Drug Revenue Market Share by Application (2017-2028)
5.3 Global Tourette Syndrome Drug Price by Application
5.3.1 Global Tourette Syndrome Drug Price by Application (2017-2022)
5.3.2 Global Tourette Syndrome Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tourette Syndrome Drug Market Size by Type
6.1.1 North America Tourette Syndrome Drug Sales by Type (2017-2028)
6.1.2 North America Tourette Syndrome Drug Revenue by Type (2017-2028)
6.2 North America Tourette Syndrome Drug Market Size by Application
6.2.1 North America Tourette Syndrome Drug Sales by Application (2017-2028)
6.2.2 North America Tourette Syndrome Drug Revenue by Application (2017-2028)
6.3 North America Tourette Syndrome Drug Market Size by Country
6.3.1 North America Tourette Syndrome Drug Sales by Country (2017-2028)
6.3.2 North America Tourette Syndrome Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Tourette Syndrome Drug Market Size by Type
7.1.1 Europe Tourette Syndrome Drug Sales by Type (2017-2028)
7.1.2 Europe Tourette Syndrome Drug Revenue by Type (2017-2028)
7.2 Europe Tourette Syndrome Drug Market Size by Application
7.2.1 Europe Tourette Syndrome Drug Sales by Application (2017-2028)
7.2.2 Europe Tourette Syndrome Drug Revenue by Application (2017-2028)
7.3 Europe Tourette Syndrome Drug Market Size by Country
7.3.1 Europe Tourette Syndrome Drug Sales by Country (2017-2028)
7.3.2 Europe Tourette Syndrome Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tourette Syndrome Drug Market Size by Type
8.1.1 Asia Pacific Tourette Syndrome Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Tourette Syndrome Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Tourette Syndrome Drug Market Size by Application
8.2.1 Asia Pacific Tourette Syndrome Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Tourette Syndrome Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Tourette Syndrome Drug Market Size by Region
8.3.1 Asia Pacific Tourette Syndrome Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Tourette Syndrome Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Tourette Syndrome Drug Market Size by Type
9.1.1 Latin America Tourette Syndrome Drug Sales by Type (2017-2028)
9.1.2 Latin America Tourette Syndrome Drug Revenue by Type (2017-2028)
9.2 Latin America Tourette Syndrome Drug Market Size by Application
9.2.1 Latin America Tourette Syndrome Drug Sales by Application (2017-2028)
9.2.2 Latin America Tourette Syndrome Drug Revenue by Application (2017-2028)
9.3 Latin America Tourette Syndrome Drug Market Size by Country
9.3.1 Latin America Tourette Syndrome Drug Sales by Country (2017-2028)
9.3.2 Latin America Tourette Syndrome Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tourette Syndrome Drug Market Size by Type
10.1.1 Middle East and Africa Tourette Syndrome Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tourette Syndrome Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Tourette Syndrome Drug Market Size by Application
10.2.1 Middle East and Africa Tourette Syndrome Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tourette Syndrome Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Tourette Syndrome Drug Market Size by Country
10.3.1 Middle East and Africa Tourette Syndrome Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abide Therapeutics Inc
11.1.1 Abide Therapeutics Inc Corporation Information
11.1.2 Abide Therapeutics Inc Overview
11.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abide Therapeutics Inc Recent Developments
11.2 Catalyst Pharmaceuticals Inc
11.2.1 Catalyst Pharmaceuticals Inc Corporation Information
11.2.2 Catalyst Pharmaceuticals Inc Overview
11.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Catalyst Pharmaceuticals Inc Recent Developments
11.3 Neurocrine Biosciences Inc
11.3.1 Neurocrine Biosciences Inc Corporation Information
11.3.2 Neurocrine Biosciences Inc Overview
11.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Neurocrine Biosciences Inc Recent Developments
11.4 Psyadon Pharmaceuticals Inc
11.4.1 Psyadon Pharmaceuticals Inc Corporation Information
11.4.2 Psyadon Pharmaceuticals Inc Overview
11.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Psyadon Pharmaceuticals Inc Recent Developments
11.5 Reviva Pharmaceuticals Inc
11.5.1 Reviva Pharmaceuticals Inc Corporation Information
11.5.2 Reviva Pharmaceuticals Inc Overview
11.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Reviva Pharmaceuticals Inc Recent Developments
11.6 Synchroneuron Inc
11.6.1 Synchroneuron Inc Corporation Information
11.6.2 Synchroneuron Inc Overview
11.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Synchroneuron Inc Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Synchroneuron Inc Recent Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.7.2 Teva Pharmaceutical Industries Ltd Overview
11.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.8 Therapix Biosciences Ltd
11.8.1 Therapix Biosciences Ltd Corporation Information
11.8.2 Therapix Biosciences Ltd Overview
11.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Therapix Biosciences Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tourette Syndrome Drug Industry Chain Analysis
12.2 Tourette Syndrome Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tourette Syndrome Drug Production Mode & Process
12.4 Tourette Syndrome Drug Sales and Marketing
12.4.1 Tourette Syndrome Drug Sales Channels
12.4.2 Tourette Syndrome Drug Distributors
12.5 Tourette Syndrome Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tourette Syndrome Drug Industry Trends
13.2 Tourette Syndrome Drug Market Drivers
13.3 Tourette Syndrome Drug Market Challenges
13.4 Tourette Syndrome Drug Market Restraints
14 Key Findings in The Global Tourette Syndrome Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer